FanDuel, a subsidiary of Flutter Entertainment, has made its debut on the New York Stock Exchange, presenting American investors with an alternative to the dominant player in the sports betting market, DraftKings. While Flutter retains its primary listing on the London Stock Exchange and its inclusion in the FTSE 100 index, the company recognizes that
Business
The world of children’s entertainment has transformed dramatically in recent years, and much of this change can be attributed to the rise of streaming platforms. Gone are the days when kids had limited options on traditional TV channels. Streaming has opened up a vast array of choices for both parents and children, allowing them to
The CEOs of Merck and Johnson & Johnson have voluntarily agreed to testify at an upcoming Senate hearing on high drug prices in the U.S. This comes as lawmakers are increasing their efforts to rein in healthcare costs for Americans. The hearing is scheduled for February 8th, and the panel had initially planned to subpoena
The Federal Aviation Administration’s (FAA) recent decision to halt Boeing’s planned expansion of its 737 Max aircraft production has raised concerns about the company’s quality control issues. While the FAA cleared the Max 9 for a return to service, it emphasized that Boeing must address the problems uncovered during the investigation. This article critically analyzes
Boeing CEO Dave Calhoun recently met with several U.S. senators on Capitol Hill seeking to address concerns surrounding the blown door plug incident that occurred on one of the company’s 737 Max 9 planes. In an effort to promote transparency, Calhoun expressed his willingness to answer all the senators’ questions, acknowledging the significant scrutiny faced
Netflix, the leading streaming service, exceeded expectations in the fourth quarter of 2023 by adding 13.1 million new subscribers. This growth surpassed Wall Street’s predictions and helped Netflix reach a record-high of 260.8 million paid subscribers. The company’s focus on an ad-supported service and cracking down on password sharing contributed to this remarkable achievement. In
The biopharmaceutical company, Gilead Sciences, suffered a significant setback as its key drug, Trodelvy, failed to significantly extend the lives of patients with a specific type of lung cancer in a late-stage trial. This news caused a drop of over 10% in Gilead’s shares on Monday. The company had high hopes for Trodelvy, as it